InsidersTradesSigma
Track the 海尔生物 share price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 海尔生物 has recorded 1 public disclosures. Market capitalisation: €8.8bn. The latest transaction was reported on 31 October 2024 (Purchase). Among the most active insiders: 江兰. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Haier Biomedical 是一家专注于医疗保健和制药领域的公司，为生物样本的存储和管理提供创新解决方案。该公司在上海证券交易所上市。